anti-EBV Early Antigens antibody product blog
Tags: Antibody; Monoclonal Antibody; EBV Early Antigens; anti-EBV Early Antigens antibody;
The EBV Early Antigens n/a (Catalog #MBS438342) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The EBV Early Antigens reacts with EBV and may cross-react with other species as described in the data sheet. MyBioSource\'s EBV Early Antigens can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence (IF).IF: (1-2ug/ml)
Optimal dilution for a specific application should be determined. Researchers should empirically determine the suitability of the EBV Early Antigens n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the EBV Early Antigens with the following immunoassay(s):
SDS-PAGE (SDS) (DS-PAGE Analysis Purified EBV Mouse Monoclonal Antibody. Confirmation of Purity and Integrity of Antibody.)
Localization: Nuclear
Positive Control: EBV-EBV-infected cells or tissues. Immunogen: Affinity purified early antigen polypeptides from induced Raji cells precipitated with African Burkitt\'s lymphoma sera. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing EBV Early Antigens are readily searchable from our website. Different antibodies against the same target such as EBV Early Antigens may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.